Thus, our previous and current findings offer novel insight into how dysregulation in the HSP60-HSP70-TLR2/4 signaling pathway may contribute to inefficient erythropoiesis and the profound, life-threatening anemia witnessed in children with SMA. This evidence concerns the gene HSPA4 and anemia.